Technical Analysis for RCPIQ - Rock Creek Pharmaceuticals Inc

Grade Last Price % Change Price Change
grade A 0.0008 0.00% 0.0000
RCPIQ closed unchanged on Friday, August 23, 2019, on 56 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical RCPIQ trend table...

Date Alert Name Type % Chg
180 Bullish Setup Bullish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
BB Squeeze + Upper Band Touch Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Above Upper BB Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
BB Squeeze + Upper Band Touch Range Contraction 0.00%

Older signals for RCPIQ ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Rock Creek Pharmaceuticals, Inc. is a pharmaceutical development company. The Company is focused on the discovery, development and commercialization of therapies for chronic inflammatory disease and neurologic disorders. The Company's activities are focused on its lead compound, anatabine citrate (anatabine). Anatabine is a small molecule, cholinergic agonist, which exhibits anti-inflammatory pharmacological characteristics. The Company focuses on dermatological skin diseases, such as psoriasis, eczema and rare or orphan skin disorders, using its formulations of anatabine. The Company has completed Phase I safety studies of its product candidate in Europe. In pre-clinical testing, anatabine demonstrates anti-inflammatory activity in a range of in vitro and in vivo assays.
Health RTT Health Sciences Medication Drug Discovery Pharmaceutical Sciences Autoimmune Diseases Psoriasis Pharmaceutical Development Dermatitis Eczema Anti Inflammatory
Is RCPIQ a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 0.0024
52 Week Low 0.0003
Average Volume 280,962
200-Day Moving Average 0.0005
50-Day Moving Average 0.0006
20-Day Moving Average 0.0006
10-Day Moving Average 0.0007
Average True Range 0.0007
ADX 13.63
+DI 36.0
-DI 32.0
Chandelier Exit (Long, 3 ATRs ) -0.0011
Chandelier Exit (Short, 3 ATRs ) 0.0026
Upper Bollinger Band 0.0008
Lower Bollinger Band 0.0004
Percent B (%b) 1.0
BandWidth 66.666667
MACD Line -0.0001
MACD Signal Line -0.0001
MACD Histogram 0.0
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0010
Resistance 3 (R3) 0.0009 0.0009 0.0009
Resistance 2 (R2) 0.0009 0.0008 0.0009 0.0009
Resistance 1 (R1) 0.0008 0.0008 0.0009 0.0009 0.0009
Pivot Point 0.0008 0.0008 0.0008 0.0008 0.0008
Support 1 (S1) 0.0007 0.0007 0.0008 0.0008 0.0007
Support 2 (S2) 0.0007 0.0007 0.0007 0.0007
Support 3 (S3) 0.0006 0.0007 0.0007
Support 4 (S4) 0.0007